Iron chelators are compounds that bind to excess iron in the body and help remove it from tissues and organs. This can be important in conditions where iron accumulation becomes toxic, such as in certain genetic disorders like hemochromatosis or in thalassemia patients who require frequent blood transfusions. Iron chelators can also be used in cancer treatment, as some tumor cells rely on iron for their growth and proliferation. By targeting and removing iron from these cells, iron chelators can inhibit their growth and potentially improve cancer outcomes. Some common iron chelators include deferoxamine, deferiprone, and deferasirox. These compounds are typically administered orally or intravenously, depending on the specific condition being treated. Iron chelation therapy is an important aspect of managing iron overload disorders and has been shown to improve outcomes and quality of life for affected individuals.